Print
Share
E-mail2009 Publications
Lynch JM, Tate SK,et al. No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. Epilepsy Res 2009, 83(1):44-51.
Need AC, Keefe RS, Ge D, et al. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Eur J Hum Genet 2009, 17(7):946-57.
Need AC, Kasperaviciute D, Cirulli ET, Goldstein DB. A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans. Genome Biol 2009, 10(1): R7.
Need AC, Ge D, Weale ME, et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 2009, 5(2): e1000373.
Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5(3): e1000421.
Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009, 360(17): 1696-8.
Siddiqui RA, Sauermann U, Altmüller J, et al. X-chromosomal variation is associated with slow progression to AIDS in HIV-1 infected women. American Journal of Human Genetics 2009; 85(2):228-39
Walley NM, Julg B, Dickson SP, et al. The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe 2009, 5(5): 408-10; author reply 418-9.
Daly AK, Donaldson PT, Bhatnagar P, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009, Jul;41(7):816-9.
Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature 2009, Aug 6;460(7256):744-7.
Thomas R, Apps R, Qi Y, et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet, 2009;41(12):1290-4.
Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461(7262):399-401.
Fuhrman LE, Goel AK, Smith J, et al. Nucleolar proteins suppress Caenorhabditis elegans innate immunity by inhibiting p53/CEP-1. PLoS Genet 2009 Sep;5(9):e1000657.
Fellay J. Host genetics influences on HIV-1 disease. Antiviral Therapy 2009; 10.3851/IMP1253
Dennis NA, Browndyke JN, Stokes J, et al. Temporal lobe functional activity and connectivity in young adult APOE epsilon4 carriers. Alzheimers Dement 2009, Sep 8. [Epub ahead of print]
Heinzen EL, Need AC, Hayden KM, et al. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis 2009, Sep 11.
Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, Sep 16;461(7265):798-801.
Urban TJ, Weintrob AC, Fellay J, et al.CCL3L1 and HIV/AIDS susceptibility. Nat Med 2009, Oct;15(10):1110-2.
Cronin KD, Ge D, Manninger P, et al. Expansion of the Parkinson disease-associated SNCA-Rep1 allele up-regulates human {alpha}-synuclein in transgenic mouse brain. Hum Mol Genet 2009.
Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009, Oct 8;461(7265):747-53. Review.
Need AC, Goldstein DB.Next generation disparities in human genomics: concerns and remedies. Trends Genet 2009, Nov;25(11):489-94.
Need AC, Attix DK, McEvoy JM, et al. A Genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum Mol Genet2009,Dec 1;18(23):4650-61
Fellay J, Ge D, Shianna KV, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009, Dec;5(12):e1000791.
